Sudeep Pharma Limited (SUDEEPPHRM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE0QPI01025
Key metrics
- Market Cap
- ₹15,098 Cr
- P/E Ratio
- 82.67
- EPS
- 16.17
- Book Value
- 79.51
- P/B Ratio
- 16.82
- ROE
- 19.25%
- ROCE
- 19.87%
- Debt / Equity
- 0.17
- Net Margin
- 27.07%
- Revenue Growth
- 28.43%
- Profit Growth
- 24.63%
- Dividend Yield
- 0.12%
- 52W High
- ₹1,337.90
- 52W Low
- ₹524.05
- Market Cap Band
- mid cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Sudeep Pharma Limited
Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in India, the United States, and internationally. The company provides mineral salts, such as iron, calcium, sodium, zinc, copper, magnesium, manganese, potassium, picolinates, simethicone, and others;It also offers micronutrient premixes and liposomal, encapsulated ingredients, spray-dried formats, granulated ingredients, and triturated for sports nutrition, medical and clinical nutrition, infant nutrition, beverages, fortified staples, functional foods, and dairy products. In addition, the company provides a range of mineral powders and granules for carbonated, non-carbonated, and nutraceutical beverages; tricalcium phosphate, dicalcium phophate, dipotassium phosphate, ferric pyrophosphate, and disodium phosphate. Sudeep Pharma Limited was incorporated in 1989 and is based in Vadodara, India.
- Headquarters
- Vadodara, India
- Employees
- 525
- Promoter Holding
- 85.14%
The full Sudeep Pharma Limited analysis
Create a free account to open the complete SUDEEPPHRM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.